Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: The exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study

Richard F. Wright, Daniel Duprez, Das Purkayastha, Rita Samuel, Keith C. Ferdinand

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: The exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study'. Together they form a unique fingerprint.

Medicine & Life Sciences